Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Matthews

Showing results (1101-1110 of 1,304) with videos related to

Pageof 131
Sort By:
Population Health Management|February 6, 2014
Impact of symptom remission on outpatient visits in depressed primary care patients treated with collaborative care management and usual careMatthew R Meunier, Kurt B Angstman, Kathy L MacLaughlin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 26, 1998
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factorsE M Kohner, S J Aldington, I M Stratton, et al.
Diabetes Care|October 22, 2008
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 studyMichael Nauck, Anders Frid, Kjeld Hermansen, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and anti-herpes-virus activity of acyclic 2'-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanineJ C Martin, D P McGee, G A Jeffrey, et al.
The Journal of Investigative Dermatology|September 25, 2018
Kindlin-1 Regulates Epidermal Growth Factor Receptor SignalingMagdalene Michael, Rumena Begum, Grace K Chan, et al.
Infectious Diseases and Therapy|February 10, 2025
Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United KingdomRachel J Oidtman, Giulio Meleleo, Oluwaseun Sharomi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1988
Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessmentA S Rudenski, D R Hadden, A B Atkinson, et al.
Biomed Research International|August 10, 2016
Systematic Analysis of the Cytokine and Anhedonia Response to Peripheral Lipopolysaccharide Administration in RatsSteven Biesmans, Liam J R Matthews, Jan A Bouwknecht, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|April 18, 2018
Development and Validation of the Foot Union Scoring Evaluation Tool for Arthrodesis of Foot StructuresTimothy A Karthas, Jeremy J Cook, Michael R Matthews, et al.
Diabetes, Obesity & Metabolism|November 26, 2009
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissueJ Jendle, M A Nauck, D R Matthews, et al.
Pageof 131

Showing results (1101-1110 of 1,304) with videos related to

Sort By:
Pageof 131
Population Health Management|February 6, 2014
Impact of symptom remission on outpatient visits in depressed primary care patients treated with collaborative care management and usual careMatthew R Meunier, Kurt B Angstman, Kathy L MacLaughlin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 26, 1998
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factorsE M Kohner, S J Aldington, I M Stratton, et al.
Diabetes Care|October 22, 2008
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 studyMichael Nauck, Anders Frid, Kjeld Hermansen, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and anti-herpes-virus activity of acyclic 2'-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanineJ C Martin, D P McGee, G A Jeffrey, et al.
The Journal of Investigative Dermatology|September 25, 2018
Kindlin-1 Regulates Epidermal Growth Factor Receptor SignalingMagdalene Michael, Rumena Begum, Grace K Chan, et al.
Infectious Diseases and Therapy|February 10, 2025
Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United KingdomRachel J Oidtman, Giulio Meleleo, Oluwaseun Sharomi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1988
Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessmentA S Rudenski, D R Hadden, A B Atkinson, et al.
Biomed Research International|August 10, 2016
Systematic Analysis of the Cytokine and Anhedonia Response to Peripheral Lipopolysaccharide Administration in RatsSteven Biesmans, Liam J R Matthews, Jan A Bouwknecht, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|April 18, 2018
Development and Validation of the Foot Union Scoring Evaluation Tool for Arthrodesis of Foot StructuresTimothy A Karthas, Jeremy J Cook, Michael R Matthews, et al.
Diabetes, Obesity & Metabolism|November 26, 2009
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissueJ Jendle, M A Nauck, D R Matthews, et al.
Pageof 131